Winthrop Capital Management’s AbbVie ABBV Stock Holding History

Winthrop Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	4,316 +13	+0.3%	+$2.8K	0.26%	65
2026 Q1	$936K	Buy	4,303 +87	+2%	+$19.3K	0.24%	68
2025 Q4	$963K	Sell	4,216 -101	-2%	-$23K	0.22%	70
2025 Q3	$1M	Buy	4,317 +70	+2%	+$14.3K	0.24%	68
2025 Q2	$788K	Buy	4,247 +1,615	+61%	+$300K	0.2%	79
2025 Q1	$551K	Hold	2,632	–	–	0.15%	92
2024 Q4	$464K	Buy	2,632 +5	+0.2%	+$919	0.12%	96
2024 Q3	$519K	Hold	2,627	–	–	0.25%	46
2024 Q2	$451K	Buy	2,627 +59	+2%	+$9.77K	0.23%	46
2024 Q1	$468K	Buy	2,568 +56	+2%	+$9.65K	0.22%	50
2023 Q4	$389K	Buy	+2,512	New	+$366K	0.13%	99

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Winthrop Capital Management's ABBV Position: Q2 2026 in Review

Winthrop Capital Management increased its AbbVie (ABBV) stake by 0.3% in Q2 2026, buying an estimated $2.8K and bringing the position to 4,316 shares worth $1.09M. The position accounts for 0.26% of the portfolio, ranked #65.

Winthrop Capital Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Winthrop Capital Management held 4,316 shares of AbbVie worth $1.09M as of Q2 2026.
Winthrop Capital Management bought 13 AbbVie shares in Q2 2026, an estimated $2.8K.
AbbVie made up 0.26% of Winthrop Capital Management's portfolio in Q2 2026, its #65 holding.
Winthrop Capital Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.